AEGiS-SAPA: Aids affecting growth in Mozambique South African Press AssociationImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Aids affecting growth in Mozambique

South African Press Association - February 8, 2008


The rapid spread of HIV/Aids is posing a huge threat to Mozambique's future growth and the sustainability of its poverty-reduction programmes, according to a World Bank report.

The report, published in January, noted that the high costs of procuring medicines and caring for those with the disease was plunging most families further into poverty.

"And once a family member's status progresses to Aids, a household has to pay for medicines, take time off production to care for the ill person and risks the loss of the main breadwinner, plunging the household into poverty," said the report.

Titled Beating the Odds: Sustaining Inclusion in Mozambique's Growing Economy, the report noted that rising infection rates indicated that risky behaviour was not changing.

Mozambique's HIV/Aids prevalence rate is officially pegged at 16,2%, while independent analysts believe it could be higher.

The report said women between the ages of 20 and 24 were four times more likely to contract the HI-virus than men in the same age bracket.

Infection rates were driven by labour migration both inside and outside the country, with the highest infection rates being in the transport corridors connecting Mozambique to its neighbours.

Urban areas in the country were most likely to have more people with the disease.

The bank suggested that the country accelerate HIV/Aids treatment programmes.

"Unless treatment programmes accelerate, Mozambique will see a loss of educated and trained people, leaving a smaller labour force," said the report.

In January, the World Bank approved a further $60-million loan to Mozambique for the country's poverty-alleviation programmes.


080208
SA080202


Copyright © 2008 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .